Article info
Perspective
The role of angiotensin receptor blockers in the prevention of cardiovascular and renal disease: time for reassessment?
- Correspondence to: Dr Flávio Danni Fuchs
, Serviço de Cardiologia, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos 2350, Porto Alegre, RS 90035-903, Brazil; ffuchs{at}hcpa.ufrgs.br
Citation
The role of angiotensin receptor blockers in the prevention of cardiovascular and renal disease: time for reassessment?
Publication history
- First published July 10, 2012.
Online issue publication
March 19, 2013
Article Versions
- Previous version (10 July 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions